The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: An in vitro study from a malaria endemic region in Yemen

Annals of Saudi Medicine

Volumn 27, Issue 6, 2007, Pages 432-436

  Al Shamahy, Hassan ^a   Al Harazy, Abdulilah Hussein ^a   Harmal, Nabil S ^a   Al Kabsi, Abdulgodos M ^a  

^a SANA A UNIVERSITY   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; MEFLOQUINE; QUININE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD SAMPLING; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE TECHNIQUE; ENDEMIC DISEASE; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; NORMAL VALUE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; SCHIZONT; YEMEN;

EID: 39049114529     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2007.432     Document Type: Article

References (23)

1. World Health Organization. World malaria report 2005, annex 1.205 (WHO/ HTM/MAL/2005.1102).
2. World Health Organization. The Use of antimalarial drugs report of an informal consultation. 2001b. WHO/CDS/RBM/2001.33.
3. World Health Organization. Guidelines for the treatment of malaria/. WHO/ HTM/MAL/2006.1108.
4. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002; 2:209-218.
5. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop 1994; 56:143-156.
6. Abdel-Hameed AA. Antimalarial drug resistance in the Eastern Mediterranean Region/Eastern Mediterranean Health Journal, 2003; 9; 4:492-508.
7. Ministry of Public Health and Population. National Malaria Control Program. The third National Seminar on Malaria& Other Vector Borne Diseases, Sana'a - Republic of Yemen, 20-22 November- 2005.
8. α. CTD/MAL/97.20. (www.who.int/ entity/drugresistance/malaria/en/markiii.pdf).
9. Asahi H, Kanazawa T. Continuous cultivation of intre-erythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitol 1994. 109:397-401.
10. Beaudoin RL, Mazier D, Hollingdale MR. In vitro cultivation of malaria parasites: exo-erythrocytic stages, p. 321-330. In Wernsdorfer WH, McGregor I (ed.), Malaria. Principles and practice of malariology, vol.1. Churchill Livingstone, Edinburgh, United Kingdom.1988.
11. Baird JK, Tiwari T, Martin GJ, et al. Chloroquine for the treatment of uncomplicated malaria in Guyana. Ann. Trop. Med. Parasitol 2002; 96:339-348.
12. Bloland PB. Drug resistance in malaria. Geneva, World Health Organization. 2001 (WHO/CDS/CSR/DRS/2001/4).
13. Checchi F, Durand R, Balkan S, et al. High Plasmodium falciparum resistance to chloroquine and sulfadoxine/pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans R Soc Trop Med Hyg 2002; 96:664-669.
14. Ciach M, Zong K, Kain KC, Crandall I. Reversal of mefloquine and quinine resistance in Plasmodium falciparum with NP30. Antimicrob Agents Chemother 2003 Aug; 47(8): 2393-2396.
15. Simpson JA, Price R, ter Kuil F, et al. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther 1999; 66:472-84.
16. Fontanet AL and Walker AM. Predictors of treatment failure in multiple drug-resistant falciparum malaria: Results from a 42-day follow-up of 224 patients in Eastern Thailand. Am J Trop Med Hyg 1993; 49: 405-472.
17. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa. Lancet Inf Dis 2003; 3:49-58.
18. ter Kuile FO, Luxemburger C, Nosten F et al. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89:660-64.
19. Djimde A. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. Journal of Infectious Diseases, 2004; 190:853-855.
20. Ringwald P. Monitoring antimalarial drug efficacy. Clinical Infectious Diseases, 2004; 38:1192-1193.
21. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva, 2003 (document WHO/HTM/RBM/2003.50).
22. Kofoed PE, Co F, Johansson P, et al. Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine/ pyrimethamine. Trans R Soc Trop Med Hyg 2002, 96:304-309.
23. Johann-Liang R, Albrecht R. Safety evaluations of drugs containing artemisinin derivatives for the treatment of malaria. Clin Infect Dis 2003 Jun 15; 36(12): 1626-1627.